In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AUDITORS’ ORATORY: How to cope with increasing transfers between notified bodies

This article was originally published in Clinica

Executive Summary

In this latest instalment of Auditors’ Oratory, Gert Bos, president of TEAM-NB and head of regulatory and clinical affairs at BSI, explains why the number of notified bodies active in the medical devices field continues to drop and cause uncertainty for industry, what the practical impact is on manufacturers and notified bodies, and how TEAM-NB are introducing solutions to help smooth out the problems that occur in these situations





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts